首页 > 市场调查报告书 > 医疗设备

细胞冷冻保存市场规模、份额及成长分析（按产品、应用、最终用途及地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900334

细胞冷冻保存市场规模、份额及成长分析（按产品、应用、最终用途及地区划分）－2026-2033年产业预测

Cell Cryopreservation Market Size, Share, and Growth Analysis, By Product (Cell Freezing Media, Equipment), By Application (Stem Cells, Oocytes and Embryotic cells), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 245 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，细胞冷冻保存市场规模将达到 107.8 亿美元，到 2025 年将达到 132.1 亿美元，到 2033 年将达到 669.6 亿美元，在预测期（2026-2033 年）内复合年增长率为 22.5%。

细胞冷冻保存已成为在极低温度下保存生物材料的重要方法，它能维持细胞代谢惰性的状态，从而避免冰晶形成和细胞损伤。该技术尤其适用于保存干细胞和活性组织，这些组织在基础研究和医学应用方面具有巨大的潜力。冷冻过程中的挑战，例如冰晶形成和渗透压衝击，如果处理不当，会导致细胞死亡。因此，冷冻保存已成为长期保存的重要解决方案。冷冻保护剂和温度控制技术的创新提高了该过程的有效性。此外，使用冷冻保存的细胞可以进行广泛的移植性品质检测，而无需获取新鲜样本。

细胞冷冻保存市场驱动因素

由于慢性病发病率上升和新型病毒的出现，全球细胞冷冻保存市场预计将迎来显着成长。科学家和临床医生对干细胞研究的深入探索，也推动了这项需求的激增。世界各地的教育机构透过津贴博士生、临床研究员和博士后研究人员，支持干细胞研究领域的创新。此外，各国政府为促进製药和生物製药领域的研究而推出的各项倡议，也进一步推动了细胞冷冻保存市场的扩张，凸显了其在推进医疗解决方案方面发挥的关键作用。

限制细胞冷冻保存市场的因素

由于有其他具有类似疗效的替代疗法，细胞冷冻保存市场的发展面临严峻挑战。这些替代疗法可能会吸引潜在用户，并转移他们对冷冻保存技术的兴趣。此外，储存和维护冷冻保存细胞的高成本也对许多生产者构成障碍，使他们难以投资这项技术。这些经济障碍可能会限製冷冻保存服务的普及，并最终阻碍市场扩张和应用。因此，竞争格局和经济因素在塑造细胞冷冻保存市场的发展趋势中发挥关键作用。

细胞冷冻保存市场趋势

细胞冷冻保存市场正经历着向玻璃化冷冻等先进技术的重大转变，这些技术强调使用高浓度冷冻保护剂进行快速冷冻。这种创新方法透过即时暴露于液态氮中来避免冰晶形成，从而显着提高细胞活力。虽然减少冰晶形成的好处显而易见，但市场也意识到高浓度冷冻保护剂可能带来的毒性问题。随着研发工作不断致力于优化这些技术，对高效安全的细胞保存解决方案的需求预计将持续成长，玻璃化冷冻技术也因此成为不断发展的细胞冷冻保存领域的关键技术。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific（US）
Merck KGaA（Germany）
GE Healthcare（US）
BioLife Solutions, Inc.（US）
Cook Medical（US）
FUJIFILM Irvine Scientific（US）
Lonza（Switzerland）
Sartorius AG（Germany）
Cytiva（US）
Corning Incorporated（US）
STEMCELL Technologies Inc.（Canada）
PromoCell GmbH（Germany）
Bio-Techne Corporation（US）
HiMedia Laboratories Pvt. Ltd.（India）
Miltenyi Biotec（Germany）
Takara Bio Inc.（Japan）
ReproCELL Inc.（Japan）
Core Dynamics, LLC（US）
Chart Industries, Inc.（US）
Worthington Industries（US）

结论与建议

简介目录

Product Code: SQMIG35J2037

Cell Cryopreservation Market size was valued at USD 10.78 Billion in 2024 and is poised to grow from USD 13.21 Billion in 2025 to USD 66.96 Billion by 2033, growing at a CAGR of 22.5% during the forecast period (2026-2033).

Cell cryopreservation is gaining traction as a crucial method for preserving biological materials at cryogenic temperatures while maintaining metabolic inactivity, which is essential for avoiding ice crystal formation and cellular damage. This technique is particularly valuable for storing stem cells and viable tissues, which have significant potential for basic research and medical applications. The challenges of freezing processes, such as crystal formation and osmotic shock, can lead to cell death if not managed properly. As a result, cryopreservation has emerged as an indispensable solution for long-term storage. Innovations in cryoprotective agents and temperature control technologies have enhanced the effectiveness of this process. Additionally, the availability of cryopreserved cells allows extensive quality testing for transplantation suitability without sourcing fresh samples.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Cryopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Cryopreservation Market Segments Analysis

Global Cell Cryopreservation Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cell Freezing Media, Equipment and Consumables. Based on Application, the market is segmented into Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes and Others. Based on End Use, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Cryopreservation Market

The global cell cryopreservation market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the emergence of new viruses. This surge in demand is complemented by a robust focus on stem cell research, as scientists and clinicians delve deeper into its potential. Educational institutions worldwide are supporting this initiative by providing grants to PhD candidates, Clinical Research Fellows, and postdoctoral researchers, fostering innovation in stem cell studies. Additionally, various government initiatives aimed at promoting research within the pharmaceutical and biopharmaceutical sectors are further propelling the expansion of the cell cryopreservation market, highlighting its critical role in advancing healthcare solutions.

Restraints in the Cell Cryopreservation Market

The growth of the cell cryopreservation market faces significant challenges due to the presence of alternative therapies that provide similar benefits. These alternatives may attract potential users, diverting interest from cryopreservation techniques. Additionally, the high costs associated with storage and maintenance of cryopreserved cells can be a deterrent for many producers, making it difficult for them to invest in this technology. These financial barriers can limit the accessibility of cryopreservation services, ultimately hindering market expansion and adoption. As a result, the competitive landscape and economic considerations play crucial roles in shaping the dynamics of the cell cryopreservation market.

Market Trends of the Cell Cryopreservation Market

The cell cryopreservation market is experiencing a notable shift towards advanced techniques such as vitrification, emphasizing rapid freezing methodologies that utilize high concentrations of cryoprotectants. This innovative approach circumvents the formation of ice crystals through immediate exposure to liquid nitrogen, significantly enhancing cell viability. While the benefits of reduced ice formation are evident, the market is also acknowledging concerns regarding potential toxicity associated with concentrated cryoprotectants. As research and development continue to focus on optimizing these techniques, the demand for effective and safe cell preservation solutions is poised for sustained growth, positioning vitrification as a key player in the evolving landscape of cellular cryopreservation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Cell Cryopreservation Market Size by Product & CAGR (2026-2033)

Market Overview
Cell Freezing Media
- Ethylene Glycol
- Dimethyl Sulfoxide
- Glycerol
- Others
Equipment
- Freezers
- Incubators
- Liquid Nitrogen Supply Tanks
Consumables
- Cryogenic vials
- Cryogenic tubes
- Cooler boxes/containers
- Others

Global Cell Cryopreservation Market Size by Application & CAGR (2026-2033)

Market Overview
Stem Cells
Oocytes and Embryotic cells
Sperm Cells
Hepatocytes
Others

Global Cell Cryopreservation Market Size by End Use & CAGR (2026-2033)

Market Overview
Biopharmaceutical & Pharmaceutical Companies
Research Institutes
Biobanks
IVF clinics
Others

Global Cell Cryopreservation Market Size & CAGR (2026-2033)

North America (Product, Application, End Use)
- US
- Canada
Europe (Product, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReproCELL Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Core Dynamics, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worthington Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments